Back
TScan Therapeutics, Inc. TCRX · Transcripts
website
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineere...138
Price0.1832
Market Cap12.88 M
Float51.47 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents